Takeda’s Plump, GV’s Yeshwant announce retirement plans

A pair of prominent industry leaders announced plans to retire this week: Takeda’s Andy Plump and GV’s Krishna Yeshwant.

First as Chief Medical and Scientific Officer and then in his current role of President of R&D, Plump has played a major role in the evolution of  Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK) from an old-fashioned Japanese pharma into a global player with innovative products and a hub in the heart of Cambridge, Mass. ...